Cdc7-IN-7 free base

Cdc7-IN-7 (compound I-E) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I-E.

For research use only. Not for human or veterinary use.

Target CDK

Research area Cancer

Purity >98% Stock Inquire

Data Sheet SDS COA

Cdc7-IN-7 structure

CAS No.: 1402059-17-9

Download structure (.mol)

Pack sizes & pricing

Size	Price	SKU	Stock
25 mg	USD 400.00	BP-01883-25mg	In stock	Get quote
50 mg	USD 585.00	BP-01883-50mg	In stock	Get quote
100 mg	USD 885.00	BP-01883-100mg	In stock	Get quote
250 mg	USD 1,285.00	BP-01883-250mg	In stock	Get quote
500 mg	USD 1,885.00	BP-01883-500mg	In stock	Get quote
1 g	Inquire	BP-01883-1g	In stock	Inquire

Need another size or custom synthesis? Request a quote.

Description

Cdc7-IN-7 (compound I-E) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I-E. Cdc7 is a serine-threonine protein kinase enzyme which is essential for the initiation of DNA replication in the cell cycle.

Identifiers

SMILES: O=C(C(C/1=O)=C(NN2CCOCC2)OC1=C/C3=CNC4=NC=CC=C43)OCC5CC5
InChIKey: ZDVDFSVUERABTR-YBEGLDIGSA-N

Specifications

MW (average): 410.4232
Formula: C₂₁H₂₂N₄O₅
CAS No.: 1402059-17-9
Physical state: Solid
Color: White to off-white
Shipping: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage: Powder -20℃ 2 years; In solvent -20℃ 1 month;

Solubility

Soluble in DMSO

Documents

References

[1]. Christian Andrew HASSIG, et al. Methods of treatment of cancer comprising cdc7 inhibitors. WO2019165473A1.

Same target

Search CDK

Same research area

Search Cancer